BCR and Bruton-type agammaglobulinemia: The role of BTK in BCR signaling was first studied in X-linked agammaglobulinemia (XLA), a B cell immunodeficiency characterized by an almost complete block of B cell development at the pre-B cell stage [32,33,34,35].